Pharmaceuticals Global On demand · 24-48h

Global CBD for Health and Wellness Market Strategic Research Report

Global CBD for Health and Wellness Market Strategic Research…
$3,500 USD
Market Research Reports
Strategic Research Report
Global CBD for Health and Wellness Market
$3.18B2025
8.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Capsules, Crystals, Gummies, Powder, Nasal Sprays, Topical Creams

By Application: Anxiety and Stress Relief, General Pain Relief (Oral), Topical Pain Relievers, Sleep Aids, Vitamins and Supplements

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Bluebird Botanicals, Bluemoon Hemp, CBD American Shaman, CBDfx, CBDistillery, Charlotte's Web, Curaleaf Hemp, CV Sciences, Diamond CBD, Elixinol LLC, Endoca BV, Functional Remedies, LLC, Irie CBD, Isodiol International, Mary's Nutritionals, Medical Marijuana

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 131 pages
Market size 2025
$3.18B
Billion USD
Forecast CAGR
8.4%
2025-2032
Forecast 2032
$5.6B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global CBD for Health and Wellness market size is predicted to grow from US$ 3,180 million in 2025 to US$ 5,537 million in 2032; it is expected to grow at a CAGR of 8.4% from 2026 to 2032.

CBD health and wellness products are those made from cannabis plant extracts, primarily containing cannabidiol (CBD). CBD is a non-psychoactive cannabinoid widely used for stress relief, anxiety reduction, sleep improvement, chronic pain, and inflammation management. With an increasing consumer demand for natural and over-the-counter health products, CBD items like oils, capsules, gummies, and topicals are gaining popularity. These products are regarded as natural remedies that support both physical health and mental well-being without the side effects often associated with traditional medications. The global production of cannabidiol (CBD) health and wellness products in 2024 is estimated to be 63.47 million units, with an average price of $47.5 per unit.

Market Overview

The CBD health and wellness product market is experiencing rapid growth globally. As consumer interest in natural health products increases, CBD products are widely used for stress relief, anxiety reduction, sleep improvement, pain management, and other wellness applications. The non-psychoactive properties of CBD make it a popular alternative therapy within the health and wellness market. As awareness of CBD's benefits continues to grow and its safety and effectiveness are validated, more individuals are incorporating CBD products into their daily health routines, driving the market's expansion.

Regional Market Structure

The North American market, particularly the United States, dominates the global CBD health and wellness product market, accounting for approximately 65% of the market share. Europe follows with about 20% of the market share. The Asia-Pacific and Latin American regions currently have smaller market shares, but with increasing consumer health awareness and the gradual relaxation of relevant regulations, these regions are expected to experience rapid growth in the coming years.

Key Manufacturers and Industry Competition

Leading manufacturers in the CBD health and wellness product market include Charlotte's Web, Endoca, Green Roads, CBD American Shaman, and NuLeaf Naturals. These companies compete fiercely in product development, marketing, and brand building. As the market matures, an increasing number of emerging brands and small to medium-sized enterprises are entering the sector, offering innovative products and customized services, thereby intensifying market competition.

Technological Trends and Innovation Directions

As technology advances, production methods for CBD health and wellness products continue to evolve. For example, supercritical CO2 extraction is widely used for CBD extraction, ensuring high efficiency and product purity. Additionally, the application of nanotechnology is enhancing CBD bioavailability, enabling faster absorption in the body. With the growing demand for personalized health management, customized CBD products and the combination with other natural ingredients are expected to be key innovation directions in the future.

Policy and Industry Development Drivers

The growth of the CBD health and wellness product market is significantly driven by changes in policies and regulations. As the United States, Europe, and other regions gradually relax their controls on CBD, the legalization of CBD products has led to rapid market expansion. Furthermore, the increasing consumer demand for natural, side-effect-free products, particularly in the field of alternative therapies, has further driven market penetration of CBD products. Ongoing regulation and standardization of CBD products across countries also provide a more stable market environment.

Key Questions Addressed in this Report

What is the 10-year outlook for the global CBD for Health and Wellness market?

What factors are driving CBD for Health and Wellness market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do CBD for Health and Wellness market opportunities vary by end market size?

How does CBD for Health and Wellness break out by Type, by Application?

This report presents a comprehensive overview of the global CBD for Health and Wellness market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Capsules
  • Crystals
  • Gummies
  • Powder
  • Nasal Sprays
  • Topical Creams

Segment by Application

  • Anxiety and Stress Relief
  • General Pain Relief (Oral)
  • Topical Pain Relievers
  • Sleep Aids
  • Vitamins and Supplements

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global CBD for Health and Wellness market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Anxiety and Stress Relief, General Pain Relief (Oral), Topical Pain Relievers evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global CBD for Health and Wellness Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$3.18B
2025
Forecast
$5.6B
2032
CAGR
8.4%
2025–2032
Régions
5
global
Key companies
Bluebird BotanicalsBluemoon HempCBD American ShamanCBDfxCBDistilleryCharlotte's WebCuraleaf HempCV Sciences
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
CapsulesCrystalsGummiesPowderNasal SpraysTopical Creams
By Application
Anxiety and Stress ReliefGeneral Pain Relief (Oral)Topical Pain RelieversSleep AidsVitamins and Supplements

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Capsules
  • 3.1.3 Crystals
  • 3.1.4 Gummies
  • 3.1.5 Powder
  • 3.1.6 Nasal Sprays
  • 3.1.7 Topical Creams
  • 3.1.8 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Anxiety and Stress Relief
  • 4.1.3 General Pain Relief (Oral)
  • 4.1.4 Topical Pain Relievers
  • 4.1.5 Sleep Aids
  • 4.1.6 Vitamins and Supplements
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Bluebird Botanicals
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Bluemoon Hemp
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 CBD American Shaman
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 CBDfx
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 CBDistillery
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Charlotte's Web
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Curaleaf Hemp
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 CV Sciences
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Diamond CBD
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Elixinol LLC
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Endoca BV
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Functional Remedies, LLC
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Irie CBD
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Isodiol International
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Mary's Nutritionals
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Medical Marijuana
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global CBD for Health and Wellness market size?
The global CBD for Health and Wellness market is estimated at US$ 3.18 billion in 2025 (base year) and is projected to reach US$ 5.54 billion by 2032.
What growth rate is expected for the CBD for Health and Wellness market through 2032?
The market is expected to grow at a CAGR of 8.4% from 2026 to 2032, expanding from US$ 3.18 billion in 2025 to US$ 5.54 billion in 2032, roughly 1.7 times its base-year value.
How is CBD for Health and Wellness defined?
CBD health and wellness products are those made from cannabis plant extracts, primarily containing cannabidiol (CBD). CBD is a non-psychoactive cannabinoid widely used for stress relief, anxiety reduction, sleep improvement, chronic pain, and inflammation management. With an increasing consumer demand for natural and over-the-counter health products, CBD items like oils, capsules, gummies, and topicals are gaining popularity.
How is the CBD for Health and Wellness market segmented by type?
By type, the market is segmented into Capsules, Crystals, Gummies, Powder, Nasal Sprays and Topical Creams.
What are the key applications of CBD for Health and Wellness?
Key applications covered include Anxiety and Stress Relief, General Pain Relief (Oral), Topical Pain Relievers, Sleep Aids and Vitamins and Supplements.
Which companies are profiled in the CBD for Health and Wellness market report?
Key players profiled include Bluebird Botanicals, Bluemoon Hemp, CBD American Shaman, CBDfx, CBDistillery, Charlotte's Web, Curaleaf Hemp and CV Sciences, among 16 companies covered in total.
What geographies does the CBD for Health and Wellness market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for CBD for Health and Wellness?
As awareness of CBD's benefits continues to grow and its safety and effectiveness are validated, more individuals are incorporating CBD products into their daily health routines, driving the market's expansion.
Who should buy the CBD for Health and Wellness market report?
The report is intended for manufacturers and solution providers, distributors and end users in Anxiety and Stress Relief, General Pain Relief (Oral) and Topical Pain Relievers, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the CBD for Health and Wellness market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.